Pregnant women are considered to be at risk of excess rates of mortality during influenza pandemics (3). Hardy et al. (8) during the Asian influenza pandemic of 1957 reported a high overall attack rate (85%) in pregnant women. During this pandemic, the outcome of pregnancy in terms of abortion, stillbirth, prematurity, neonatal morbidity, neonatal death, or congenital malformation could not be demonstrated to be different from experiences in previous and subsequent years (8) or from that of noninfected pregnant women (15) .
There have been no adequately controlled studies of the protective effect of immunization during pregnancy in terms of either prevention of maternal disease or effect on pregnancy outcome (7) . After the decision to implement a mass immunization program with A/New Jersey/8/ 76 (HswlN1) influenza vaccine, a study was designed to evaluate the effect of immunization for swine influenza vaccine on pregnant women. However, since the swine influenza vaccination program was terminated in February of 1977, the number of pregnant women enrolled in this study was too small to determine the effect of the vaccine on pregnancy outcome.
This report, however, summarizes the results of the antibody responses in pregnant women enrolled in the study and examines the immunogenicity of monovalent A/New Jersey/8/76 
a All pre-immunization titers were <10.
b Number of subjects who responded with antibody titers at levels indicated.
and 35% had HI titers >40. The response to influenza A/New Jersey/8/76 (HswlNl) antigen at HI >20 was fairly uniform regardless of trimester of pregnancy. Figure 1 indicates the result of treatment of the sera with 2-mercaptoethanol. Only sera with post-immunization HI titers -10 were treated with 2-mercaptoethanol. The mean fold reduction in titer was fairly uniform and not statistically different in comparing various trimesters or in pregnant and nonpregnant groups.
When the heterologous antibody responses to influenza A/Japan/305/57 (H2N2) and influenza A/Hong Kong/8/68 (H3N2) were examined after immunization with influenza A/New Jersey/8/76 (HswlNl) vaccine, there was, as one would expect, a much higher mean fold rise to influenza A/New Jersey/8/76 than to the other antigens. Both groups, pregnant and nonpregnant, exhibited previous exposure to (14) . High mortality in puerperal women during the 1918 to 1920 pandemic was well recognized (3, 8) . Transplacental transfer of influenza virus during infection in the mother has occurred (16) , and during pandemics a high incidence of abortions has been recorded. The need for a study to determine the effectiveness of influenza vaccines for the protection of susceptible pregnant women is evident. Immunological responses during pregnancy are poorly defined. One study showed a slight but gradual decline in blood levels of IgG toward the end of pregnancy and also postpartum, but this was considered to represent increased placental transfer of antibody to the fetus rather than decreased maternal antibody production (10) . Immunization of pregnant women to a variety of antigens has shown no consistent weakening of the immune response (13) . In general, the capacity to synthesize antibody during pregnancy has been thought to be at least equivalent to that of nonpregnant individuals.
In this study, we found no significant difference, in age-matched (age 24-34) 
